Transferrin-Decorated Niosomes with Integrated InP/ZnS Quantum Dots and Magnetic Iron Oxide Nanoparticles: Dual Targeting and Imaging of Glioma.


Journal

International journal of molecular sciences
ISSN: 1422-0067
Titre abrégé: Int J Mol Sci
Pays: Switzerland
ID NLM: 101092791

Informations de publication

Date de publication:
27 Apr 2021
Historique:
received: 24 03 2021
revised: 22 04 2021
accepted: 23 04 2021
entrez: 30 4 2021
pubmed: 1 5 2021
medline: 8 6 2021
Statut: epublish

Résumé

The development of multifunctional nanoscale systems that can mediate efficient tumor targeting, together with high cellular internalization, is crucial for the diagnosis of glioma. The combination of imaging agents into one platform provides dual imaging and allows further surface modification with targeting ligands for specific glioma detection. Herein, transferrin (Tf)-decorated niosomes with integrated magnetic iron oxide nanoparticles (MIONs) and quantum dots (QDs) were formulated (PEGNIO/QDs/MIONs/Tf) for efficient imaging of glioma, supported by magnetic and active targeting. Transmission electron microscopy confirmed the complete co-encapsulation of MIONs and QDs in the niosomes. Flow cytometry analysis demonstrated enhanced cellular uptake of the niosomal formulation by glioma cells. In vitro imaging studies showed that PEGNIO/QDs/MIONs/Tf produces an obvious negative-contrast enhancement effect on glioma cells by magnetic resonance imaging (MRI) and also improved fluorescence intensity under fluorescence microscopy. This novel platform represents the first niosome-based system which combines magnetic nanoparticles and QDs, and has application potential in dual-targeted imaging of glioma.

Identifiants

pubmed: 33925347
pii: ijms22094556
doi: 10.3390/ijms22094556
pmc: PMC8123697
pii:
doi:

Substances chimiques

Contrast Media 0
Ferric Compounds 0
Liposomes 0
Transferrin 0
ferric oxide 1K09F3G675
Polyethylene Glycols 3WJQ0SDW1A

Types de publication

Journal Article

Langues

eng

Sous-ensembles de citation

IM

Références

Ther Deliv. 2013 May;4(5):629-40
pubmed: 23647279
Adv Healthc Mater. 2018 May;7(9):e1701130
pubmed: 29350498
Biomaterials. 2012 Apr;33(12):3494-501
pubmed: 22306020
ACS Appl Mater Interfaces. 2017 Aug 30;9(34):28959-28966
pubmed: 28786283
Avicenna J Med Biotechnol. 2017 Oct-Dec;9(4):181-188
pubmed: 29090067
Biomacromolecules. 2013 Oct 14;14(10):3532-41
pubmed: 23987303
Sci Rep. 2020 Feb 11;10(1):2320
pubmed: 32047170
Int J Nanomedicine. 2018 Jul 04;13:3921-3935
pubmed: 30013345
Curr Drug Metab. 2013 Oct;14(8):847-56
pubmed: 24016111
PLoS One. 2015 Jul 17;10(7):e0132887
pubmed: 26186462
Nanoscale. 2015 Feb 7;7(5):1782-90
pubmed: 25519743
J Phys Chem B. 2005 Mar 10;109(9):3879-85
pubmed: 16851439
Bioconjug Chem. 2006 May-Jun;17(3):773-80
pubmed: 16704217
Pharmaceutics. 2021 Mar 16;13(3):
pubmed: 33809700
J Vis Exp. 2016 Feb 06;(108):e53684
pubmed: 26891282
Drug Deliv Transl Res. 2018 Oct;8(5):1545-1563
pubmed: 29916012
Theranostics. 2018 Apr 3;8(9):2508-2520
pubmed: 29721096
Colloids Surf B Biointerfaces. 2014 Feb 1;114:96-103
pubmed: 24176888
Chem Sci. 2017 May 1;8(5):3879-3884
pubmed: 28626557
Mol Ther. 2014 Feb;22(2):278-291
pubmed: 24113515
Pharmaceutics. 2019 Jan 29;11(2):
pubmed: 30700021
Nanomedicine. 2015 Feb;11(2):341-50
pubmed: 25461291
Transl Oncol. 2010 Apr;3(2):123-34
pubmed: 20360937
Inorg Chem. 2013 Dec 16;52(24):14284-93
pubmed: 24304423
Exp Ther Med. 2016 Dec;12(6):3778-3784
pubmed: 28105110
ACS Appl Mater Interfaces. 2017 Feb 1;9(4):3455-3462
pubmed: 28079361
Int J Mol Sci. 2019 Sep 22;20(19):
pubmed: 31546717
Drug Deliv. 2016 May;23(4):1261-71
pubmed: 26961144
Front Chem. 2019 Jun 27;7:466
pubmed: 31316974
Bioconjug Chem. 2016 Feb 17;27(2):414-26
pubmed: 26567697
Int J Mol Sci. 2017 Jul 02;18(7):
pubmed: 28671589
Angew Chem Int Ed Engl. 2006 Aug 18;45(33):5478-83
pubmed: 16847983
Nanotechnology. 2015 May 1;26(17):175302
pubmed: 25850702
Nanoscale. 2016 Apr 21;8(15):7808-26
pubmed: 27029509
Analyst. 2018 May 29;143(11):2469-2478
pubmed: 29736519
ACS Appl Mater Interfaces. 2016 Oct 19;8(41):27465-27473
pubmed: 27466824
J Drug Target. 2019 Jun - Jul;27(5-6):601-613
pubmed: 30475084
Nanomaterials (Basel). 2021 Mar 18;11(3):
pubmed: 33803751
Small. 2008 Sep;4(9):1406-15
pubmed: 18711753
Brain Sci. 2018 Jan 16;8(1):
pubmed: 29337870
PLoS One. 2012;7(5):e37376
pubmed: 22615995
Sci Rep. 2016 Mar 02;6:22368
pubmed: 26931282
J Nanomed Nanotechnol. 2016 Aug;7(4):
pubmed: 27695645

Auteurs

Didem Ag Seleci (D)

Institute for Particle Technology (iPAT), Technische Universität Braunschweig, 38104 Braunschweig, Germany.
Center of Pharmaceutical Engineering (PVZ), Technische Universität Braunschweig, 38106 Braunschweig, Germany.

Viktor Maurer (V)

Institute for Particle Technology (iPAT), Technische Universität Braunschweig, 38104 Braunschweig, Germany.
Center of Pharmaceutical Engineering (PVZ), Technische Universität Braunschweig, 38106 Braunschweig, Germany.

Firat Baris Barlas (FB)

Faculty of Science Biochemistry Department, Ege University, 35100 Izmir, Turkey.

Julian Cedric Porsiel (JC)

Institute for Particle Technology (iPAT), Technische Universität Braunschweig, 38104 Braunschweig, Germany.

Bilal Temel (B)

Institute for Particle Technology (iPAT), Technische Universität Braunschweig, 38104 Braunschweig, Germany.

Elcin Ceylan (E)

Faculty of Science Biochemistry Department, Ege University, 35100 Izmir, Turkey.

Suna Timur (S)

Faculty of Science Biochemistry Department, Ege University, 35100 Izmir, Turkey.

Frank Stahl (F)

Institute for Technical Chemistry, Leibniz University Hannover, 30167 Hannover, Germany.

Thomas Scheper (T)

Institute for Technical Chemistry, Leibniz University Hannover, 30167 Hannover, Germany.

Georg Garnweitner (G)

Institute for Particle Technology (iPAT), Technische Universität Braunschweig, 38104 Braunschweig, Germany.
Center of Pharmaceutical Engineering (PVZ), Technische Universität Braunschweig, 38106 Braunschweig, Germany.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH